| P50 | author | Margaret A. Pericak-Vance | Q28554103 |
| | Cyrus P Zabetian | Q30362040 |
| | Eden R Martin | Q67215561 |
| | Jonathan L Haines | Q73570557 |
| | Gary W Beecham | Q124706380 |
| P2093 | author name string | Jeffery M Vance | |
| | William K Scott | |
| | Liyong Wang | |
| | Haydeh Payami | |
| | James C Ritchie | |
| | Marian L Evatt | |
| | Lizmarie Maldonado | |
| P2860 | cites work | Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffee | Q21092426 |
| | A flexible and accurate genotype imputation method for the next generation of genome-wide association studies | Q21129496 |
| | Parkinson's disease: from monogenic forms to genetic susceptibility factors | Q22242870 |
| | Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease | Q24596763 |
| | Calcium, bioenergetics, and neuronal vulnerability in Parkinson's disease | Q26853225 |
| | Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease | Q28192834 |
| | Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease | Q28222196 |
| | Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease | Q28244731 |
| | Genome-wide association study identifies five new schizophrenia loci | Q28248384 |
| | Genome-wide association analysis identifies 13 new risk loci for schizophrenia | Q28297287 |
| | 'Rejuvenation' protects neurons in mouse models of Parkinson's disease | Q28305585 |
| | Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease | Q28943440 |
| | Annotation of functional variation in personal genomes using RegulomeDB | Q29614867 |
| | L-type calcium channel blockers and Parkinson disease in Denmark | Q30495902 |
| | The C-3 epimer of 25-hydroxyvitamin D(3) is present in adult serum | Q33452232 |
| | The effects of vitamin D receptor silencing on the expression of LVSCC-A1C and LVSCC-A1D and the release of NGF in cortical neurons | Q33847890 |
| | Genomic determinants of gene regulation by 1,25-dihydroxyvitamin D3 during osteoblast-lineage cell differentiation | Q33888569 |
| | A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution | Q34153604 |
| | A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease | Q34526685 |
| | Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease | Q34598371 |
| | A role for noncoding variation in schizophrenia | Q34632245 |
| | Serum vitamin D and the risk of Parkinson disease | Q34962536 |
| | Vitamin D from different sources is inversely associated with Parkinson disease | Q35327512 |
| | The L-type channel antagonist isradipine is neuroprotective in a mouse model of Parkinson's disease | Q35607214 |
| | Meta-analysis of gene-environment interaction: joint estimation of SNP and SNP × environment regression coefficients | Q35852977 |
| | Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons | Q37180671 |
| | Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study | Q37463473 |
| | A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms | Q43483189 |
| | Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. | Q43517443 |
| | Use of calcium channel blockers and Parkinson's disease | Q46063768 |
| | Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms | Q46231296 |
| | Brain function in carriers of a genome-wide supported bipolar disorder variant | Q48102784 |
| | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level | Q48858572 |
| | L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats | Q48911406 |
| | NOS2A and the modulating effect of cigarette smoking in Parkinson's disease. | Q51938289 |
| | Professional exposure to pesticides and Parkinson disease. | Q52699602 |
| | Determination of the correct reference frame from an atomic coordinate list | Q68543424 |
| | Exploiting gene-environment interaction to detect genetic associations | Q79731627 |
| | Family-based case-control study of cigarette smoking and Parkinson disease | Q81378448 |
| | Functional implications of a psychiatric risk variant within CACNA1C in induced human neurons | Q86604437 |
| P433 | issue | 3 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| | vitamin D | Q175621 |
| P304 | page(s) | e72 | |
| P577 | publication date | 2016-04-12 | |
| P1433 | published in | Neurology. Genetics | Q27727179 |
| P1476 | title | DNA variants in CACNA1C modify Parkinson disease risk only when vitamin D level is deficient | |
| P478 | volume | 2 | |